Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viveve Medical Inc (NQ: VIVE ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Viveve Medical Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Monday's Pre-Market Session December 20, 2021 Gainers Intra-Cellular Therapies (NASDAQ:ITCI) stock rose 18.79% to $46.52 during Monday's pre-market session. The market value of their outstanding shares is at $3.7... Via Benzinga Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence December 14, 2021 Major milestone achieved in Company's advance toward a new U.S. SUI indication ENGLEWOOD, CO / ACCESSWIRE / December 14, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused... From Viveve Medical, Inc. Via AccessWire Exposures Product Safety Viveve Reports Third Quarter 2021 Financial Results and Provides Corporate Update November 11, 2021 - Total revenue of $1.6M reported for Q3 - Pivotal SUI PURSUIT trial enrollment nears completion - randomizations on-track for completion in Q4 ENGLEWOOD, CO / ACCESSWIRE / November 11, 2021 / Viveve... From Viveve Medical, Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety Earnings Scheduled For November 11, 2021 November 11, 2021 Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... Via Benzinga The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline August 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business August 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update November 02, 2021 ENGLEWOOD, CO / ACCESSWIRE / November 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its third... From Viveve Medical, Inc. Via AccessWire Exposures COVID-19 Product Safety Viveve Announces Issuance of New Device and Methods Patent in U.S October 28, 2021 Issuance further expands and strengthens Company's intellectual property portfolio ENGLEWOOD, CO / ACCESSWIRE / October 28, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company... From Viveve Medical, Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety 12 Health Care Stocks Moving In Thursday's After-Market Session October 21, 2021 Gainers T2 Biosystems (NASDAQ:TTOO) shar... Via Benzinga Viveve Medical's Return On Capital Employed Overview September 30, 2021 According to data from Benzinga Pro, during Q2, Viveve Medical's (NASDAQ:VIVE) reported sales totaled $1.65 million. Despite a 3.59% increase in earnings, the company posted a... Via Benzinga The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia September 23, 2021 Patent strengthens and expands Viveve's intellectual property portfolio for the treatment of stress urinary incontinence ENGLEWOOD, CO / ACCESSWIRE / September 23, 2021 / Viveve Medical, Inc.... From Viveve Medical, Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs September 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session September 20, 2021 Gainers Atea Pharmaceuticals (NASDAQ:AVIR) shares increased by 13.83% to $29.86 during Monday's regular session. Trading volume for this security as of 12:30 EST is 3.... Via Benzinga Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference September 07, 2021 ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive... From Viveve Medical, Inc. Via AccessWire Exposures COVID-19 Product Safety Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update August 12, 2021 Total revenue of $1.7M reported for Q2 Reported sales of approximately 3,500 consumable treatment tips - a 42% unit increase quarter-over-quarter Pivotal SUI PURSUIT trial enrollment on-track for... From Viveve Medical, Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety Preview: Viveve Medical's Earnings August 11, 2021 On Thursday, August 12, Viveve Medical (NASDAQ:VIVE) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And... Via Benzinga The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety Earnings Scheduled For August 12, 2021 August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... Via Benzinga The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... Via Benzinga Exposures Product Safety Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update August 05, 2021 ENGLEWOOD, CO / ACCESSWIRE / August 5, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its second quarter... From Viveve Medical, Inc. Via AccessWire Exposures COVID-19 Product Safety Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent August 03, 2021 ENGLEWOOD, CO / ACCESSWIRE / August 3, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Canadian Intellectual... From Viveve Medical, Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure July 07, 2021 New code approved by American Medical Association and supported by key medical societies Long-term pathway for potential reimbursement now established for Company's dual-energy noninvasive treatment... From Viveve Medical, Inc. Via AccessWire Exposures COVID-19 Product Safety Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference July 06, 2021 ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive... From Viveve Medical, Inc. Via AccessWire Exposures COVID-19 Product Safety Viveve Announces Issuance of New Device and Methods Patent in U.S. June 10, 2021 ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and... From Viveve Medical, Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 03, 2021 Gainers Sundial Growers (NASDAQ:SNDL) shares rose 9.73% to $1.24 during Thursday's pre-market session. The company's market cap stands at $2.3 billion. La Jolla... Via Benzinga Viveve Announces Adjournment of Annual Meeting June 02, 2021 Meeting scheduled to reconvene June 23, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / June 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE),... From Viveve Medical, Inc. Via AccessWire Exposures COVID-19 Product Safety < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
